Cerebras Systems experienced a remarkable initial public offering (IPO) on Thursday, generating billions for the company, its founders, and its major investors. One significant winner from this financial triumph is Benchmark, which owns a 9.5% stake in Cerebras. Eric Vishria, a general partner at Benchmark, has been on the board since the company’s inception in 2016, co-leading its $25 million Series A funding round.
Vishria’s encounter with Cerebras was initially reluctant. He recalls that he was hesitant to meet with the startup, describing it as a session with “five founders and a deck,” and noted that it was Benchmark’s first hardware investment in a decade. Reflecting on his early career as a venture capitalist, which he had been at for just 18 months, he questioned why he had accepted the meeting at all. “Why did I take this meeting?” he recalled muttering repeatedly. His uncertainty was compounded when he messaged his assistant, expressing frustration over being scheduled for the meeting.
However, Vishria’s skepticism quickly dissipated by the third slide of the presentation. Cerebras co-founder and CEO Andrew Feldman presented bold ambitions that captivated Vishria’s interest. Feldman outlined the inadequacies of GPUs for deep learning, suggesting that although GPUs were superior to CPUs, they were still not ideal for AI applications. This revelation sparked a significant realization for Vishria, who acknowledged the potential disruptiveness of Cerebras’ innovative approach.
The startup was advocating for a new type of colossal chip tailored for AI training—an endeavor that the processor industry was unprepared for at the time. Intrigued, Vishria sought to consult with other Benchmark partners, but they too were unfamiliar with the hardware landscape. To proceed, they insisted that one of the original Benchmark founders, known for his hardware expertise, should evaluate the pitch.
A subsequent meeting was arranged, allowing Feldman to present to Benchmark founding partner Bruce Dunlevie. Despite lacking a deep understanding of the technological aspects, Vishria found the experience amusing. Dunlevie was skeptical, cautioning that many had attempted to achieve what Cerebras was aiming for but had failed. Nonetheless, he saw potential in the team’s capabilities, which included seasoned professionals who had previously sold their startup, SeaMicro, to AMD.
Vishria’s instincts told him that if Cerebras could expedite AI processing, there would undoubtedly be a market for its product. However, the journey was fraught with challenges. Over the following eight and a half years, Cerebras faced numerous hurdles, such as developing new cooling systems to manage the heat generated by their large chips and devising machinery capable of handling the precision assembly of such extensive components.
Along the way, the team struggled to secure funding. Even after raising significant capital, they had to navigate a difficult venture capital bear market to continue developments on their chips.
Despite these challenges, a pivotal shift occurred around 18 months ago. The chips, initially designed for training, were proving even more effective for inference—processing AI models to generate responses. This development coincided with an escalating demand for high computational power in the AI sector, leading to considerable customer interest and revenue growth.
Cerebras aimed for the public markets in 2024 but encountered delays due to regulatory scrutiny and investor hesitance regarding their financial losses and dependence on a major customer, the Abu Dhabi-based G42. Ultimately, these setbacks turned out to be fortuitous, as the company later secured contracts with major players like OpenAI and AWS, doubling revenues and achieving profitability.
Vishria attributes the success to the Cerebras team’s persistence, ingenuity, and adaptability. The IPO has proven to be immensely beneficial for Benchmark as well, with their initial investment of approximately $270 million yielding a stake valued at around $3.3 billion at the IPO’s opening price and possibly exceeding $5.3 billion based on increased trading values. While Benchmark is unable to sell shares immediately due to a standard six-month lockup period, the potential financial gains have left the firm in a favorable position.
Reflecting on the journey, Vishria humorously acknowledged his assistant’s role in facilitating that initial meeting, suggesting she would be well-rewarded for her part in the firm’s surprising success.
